deltatrials
Recruiting OBSERVATIONAL NCT03067467

Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI) (HPCIM)

Investigating Metabolic Characteristics of Intracranial Malignancy In Vivo Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

Sponsor: University of Texas Southwestern Medical Center

Conditions Brain Tumor Adult
Interventions Gadolinium Hyperpolarized 13C-Pyruvate
Updated 20 times since 2017 Last updated: Mar 6, 2026 Started: Jun 1, 2019 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Brain Tumor Adult and is currently actively recruiting participants. University of Texas Southwestern Medical Center leads this study, which shows 20 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~May 2017 – ~Jun 2018 · 13 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Apr 2019 · 4 months · monthly snapshot~Apr 2019 – ~Oct 2019 · 6 months · monthly snapshot~Oct 2019 – ~Oct 2020 · 12 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~Apr 2022 · 10 months · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jun 2023 · 12 months · monthly snapshot~Jun 2023 – ~Apr 2024 · 10 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Mar 2026 · 11 months · monthly snapshot~Mar 2026 – present · 4 months · monthly snapshot

Change History

20 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting

  2. Apr 2025 — Mar 2026 [monthly]

    Recruiting

  3. Sep 2024 — Apr 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Apr 2024 — Jul 2024 [monthly]

    Recruiting

▶ Show 15 earlier versions

  1. Jun 2023 — Apr 2024 [monthly]

    Recruiting

  2. Jun 2022 — Jun 2023 [monthly]

    Recruiting

  3. May 2022 — Jun 2022 [monthly]

    Recruiting

  4. Apr 2022 — May 2022 [monthly]

    Recruiting

  5. Jun 2021 — Apr 2022 [monthly]

    Recruiting

    Phase: EARLY_PHASE1 → None

  6. Mar 2021 — Jun 2021 [monthly]

    Recruiting EARLY_PHASE1

  7. Jan 2021 — Mar 2021 [monthly]

    Recruiting EARLY_PHASE1

  8. Dec 2020 — Jan 2021 [monthly]

    Recruiting EARLY_PHASE1

  9. Nov 2020 — Dec 2020 [monthly]

    Recruiting EARLY_PHASE1

  10. Oct 2020 — Nov 2020 [monthly]

    Recruiting EARLY_PHASE1

    Status: Active Not Recruiting → Recruiting

  11. Oct 2019 — Oct 2020 [monthly]

    Active Not Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Active Not Recruiting

  12. Apr 2019 — Oct 2019 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  13. Dec 2018 — Apr 2019 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  14. Jun 2018 — Dec 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

  15. May 2017 — Jun 2018 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Texas Southwestern Medical Center
Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations